Incidence of pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients

American Journal of Medicine

Volumn 127, Issue 12, 2014, Pages 1242.e11-1242.e17

  Fillatre, Pierre ^a,b   Decaux, Olivier ^c   Jouneau, Stéphane ^a,d   Revest, Matthieu ^a,b   Gacouin, Arnaud ^a,b   Robert Gangneux, Florence ^a,d   Fresnel, Annie ^a   Guiguen, Claude ^a,d   Le Tulzo, Yves ^a,b   Jégo, Patrick ^c   Tattevin, Pierre ^a,b,e  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

^e UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Hematological malignancy; HIV negative; Inflammatory diseases; Organ transplant; Pneumocystis jiroveci; Vasculitis

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HODGKIN DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS NEGATIVE PATIENT; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION RISK; INFLAMMATORY DISEASE; INTERMEDIATE RISK PATIENT; INTERNATIONAL CLASSIFICATION OF DISEASES; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PATIENT; PATIENT RISK; PNEUMOCYSTIS PNEUMONIA; POLYARTERITIS NODOSA; POLYMYOSITIS; RETROSPECTIVE STUDY; SOLID TUMOR; VASCULITIS; WALDENSTROEM MACROGLOBULINEMIA; WEGENER GRANULOMATOSIS; FRANCE; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; NEOPLASMS; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; REHABILITATION; RHEUMATIC DISEASES; RISK; STATISTICAL MODEL;

IMMUNOSUPPRESSIVE AGENT;

FRANCE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; NEOPLASMS; ODDS RATIO; ORGAN TRANSPLANTATION; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; VASCULITIS;

EID: 84919608640     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.07.010     Document Type: Article

References (29)

1. P. Fillatre, S. Chevrier, and M. Revest Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia Eur J Clin Microbiol Infect Dis 32 2013 189 194
2. K.A. Sepkowitz Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome Clin Infect Dis 34 2002 1098 1107
3. W.T. Hughes, S. Kuhn, and S. Chaudhary Successful chemoprophylaxis for Pneumocystis carinii pneumonitis N Engl J Med 297 1977 1419 1426
4. J.A. Kovacs, and H. Masur Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment JAMA 301 2009 2578 2585
5. A.H. Limper, K.S. Knox, and G.A. Sarosi An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients Am J Respir Crit Care Med 183 2011 96 128
6. M. Rodriguez, and J.A. Fishman Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients Clin Microbiol Rev 17 2004 770 782
7. M. Olsson, K. Stralin, and H. Holmberg Clinical significance of nested polymerase chain reaction and immunofluorescence for detection of Pneumocystis carinii pneumonia Clin Microbiol Infect 7 2001 492 497
8. X. Monnet, E. Vidal-Petiot, and D. Osman Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection Crit Care 12 2008 R28
9. S.H. Yale, and A.H. Limper Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy Mayo Clin Proc 71 1996 5 13
10. B. Godeau, V. Coutant-Perronne, and D. Le Thi Huong Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases J Rheumatol 21 1994 246 251
11. J.G. Gerrard Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults Med J Aust 162 1995 233 235
12. M.M. Ward, and F. Donald Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality Arthritis Rheum 42 1999 780 789
13. J.A. Fishman Prevention of infection caused by Pneumocystis carinii in transplant recipients Clin Infect Dis 33 2001 1397 1405
14. W.T. Hughes, R.A. Price, H.K. Kim, T.P. Coburn, D. Grigsby, and S. Feldman Pneumocystis carinii pneumonitis in children with malignancies J Pediatr 82 1973 404 415
15. S.I. Martin, and J.A. Fishman Pneumocystis pneumonia in solid organ transplantation Am J Transplant 13 Suppl 4 2013 272 279
16. Kidney Disease Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients Am J Transplant 9 Suppl 3 2009 S1 S155
17. C.A. Dykewicz Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients Clin Infect Dis 33 2001 139 144
18. K.A. Sepkowitz, A.E. Brown, E.E. Telzak, S. Gottlieb, and D. Armstrong Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital JAMA 267 1992 832 837
19. J.A. Gomes, R.D. Stevens, J.J. Lewin 3rd, M.A. Mirski, and A. Bhardwaj Glucocorticoid therapy in neurologic critical care Crit Care Med 33 2005 1214 1224
20. S. Neumann, S.W. Krause, G. Maschmeyer, X. Schiel, and M. von Lilienfeld-Toal Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Ann Hematol 92 2013 433 442
21. K.M. Obeid, J. Aguilar, and S. Szpunar Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders Clin Lymphoma Myeloma Leuk 12 2012 66 69
22. F.P. Ognibene, J.H. Shelhamer, and G.S. Hoffman Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis Am J Respir Crit Care Med 151 1995 795 799
23. S. Mori, and M. Sugimoto Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis Rheumatology (Oxford) 51 2012 2120 2130
24. V. Lufft, V. Kliem, M. Behrend, R. Pichlmayr, K.M. Koch, and R. Brunkhorst Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression Transplantation 62 1996 421 423
25. I. Martin-Garrido, E.M. Carmona, U. Specks, and A.H. Limper Pneumocystis pneumonia in patients treated with rituximab Chest 144 2013 258 265
26. E. Besada, and J.C. Nossent Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis? Clin Rheumatol 32 2013 1677 1681
27. Y. Komano, M. Harigai, and R. Koike Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients Arthritis Rheum 61 2009 305 312
28. N.G. Mansharamani, D. Balachandran, I. Vernovsky, R. Garland, and H. Koziel Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection Chest 118 2000 712 720
29. H. Green, M. Paul, L. Vidal, and L. Leibovici Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials Mayo Clin Proc 82 2007 1052 1059